[ET Net News Agency, 16 April 2025] HANSOH PHARMA (03692) fell 3.2% to HK$21.45.
It hits an intra-day low of HK$21.45, dipping below the 20-D SMA of HK$22.12, and an
intra-day high of HK$22.15. The total shares traded was 4 million, with a value of
HK$86.98m. The active buy/sell ratio is 59:41, with net buying turnover of HK$15.29m. UBS
accounts for greatest net responsive buying turnover of HK$3.94m, with volume weighted
average price of HK$21.782. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive
selling turnover of HK$6.7m, with volume weighted average price of HK$21.743. The stock
has fallen a combined 5.9% over the past 2 consecutive trading days.
The Hang Seng Index now fell 473 points, or 2.2% to 20,992.

Basic Information
=================

---------------------------------
Nominal 21.450 % Chg -3.16%
High 22.150 Low 21.450
Shares Tr 4m Turnover 86.98m
10-D SMA 22.290 %H.V 72.614
20-D SMA 22.120 VWAP 21.734
50-D SMA 19.969 RSI14 50.267
---------------------------------
Status: Dipping below the 20-D SMA, active buy/sell ratio is 59:41, with net buying
turnover of HK$15.29m, falling a combined 5.9% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 21.450 -3.16
SIHUAN PHARM (00460) 0.610 -4.69
GRAND PHARMA (00512) 5.490 -1.96
SINO BIOPHARM (01177) 3.550 -4.57
LIVZON PHARMA (01513) 25.600 -1.92
LUYE PHARMA (02186) 1.800 -3.23
FOSUN PHARMA (02196) 13.820 -3.09
UNI HEALTH (02211) 0.112 -1.75
SH PHARMA (02607) 10.740 -1.65
CHINARES PHARMA (03320) 4.840 -2.42
-----------------------------------------------
(ed)